Protocol # CIP-09: The REFLECT Trial: A Randomized Evaluation of the TriGuard™ HDH Embolic Deflection Device to Reduce the Impact of Cerebral Embolic Lesions after TransCatheter Aortic Valve Implantation

Project: Research project

StatusActive
Effective start/end date11/4/1611/4/22

Funding

  • Keystone Heart Ltd. (Protocol # CIP-09)